146 related articles for article (PubMed ID: 3502020)
21. Fine structure of lymphocytes from an immune deficient child before and after administration of transfer factor.
Criswell BS; South MA; Jordan HW; Kimzey SL; Montgomery JR; Heim LR
Exp Hematol; 1975 Sep; 3(5):327-35. PubMed ID: 1175703
[TBL] [Abstract][Full Text] [Related]
22. Chronic mucocutaneous candidiasis.
J Cutan Pathol; 1974; 1(5):211-29. PubMed ID: 4470726
[No Abstract] [Full Text] [Related]
23. T and B lymphocytes in atopic eczema.
Luckasen JR; Sabad A; Goltz RW; Kersey JH
Arch Dermatol; 1974 Sep; 110(3):375-7. PubMed ID: 4548835
[No Abstract] [Full Text] [Related]
24. [Treatment of the primary immunodeficiency diseases. Present state of the art (author's transl)].
Fontán G; García Rodríguez MC; Ojeda JA
An Esp Pediatr; 1981 Dec; 15(6):563-72. PubMed ID: 6175263
[No Abstract] [Full Text] [Related]
25. Immunologic reconstitution, autoimmunity, and T-cell immune deficiencies.
Ballow M; McLean RH; Damjanov I; Lowenstein MB
Cell Immunol; 1979 Jul; 45(2):364-76. PubMed ID: 380821
[No Abstract] [Full Text] [Related]
26. Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor.
Ballow M; Good RA
Cell Immunol; 1975 Oct; 19(2):219-29. PubMed ID: 1081434
[No Abstract] [Full Text] [Related]
27. [Secondary post-traumatic immunodeficiency syndrome in patients in the anesthesiology-resuscitation department. Possibilities of immunomodulation therapy].
Průcha M; Limberk B
Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):116-20. PubMed ID: 1339602
[TBL] [Abstract][Full Text] [Related]
28. [Clinical forms and methods of treating immunodeficient states in children].
Lopukhin IuM; Martynova MI; Koval'chuk LV; Khakhalin LN
Vopr Okhr Materin Det; 1976 Nov; 21(11):15-20. PubMed ID: 795151
[No Abstract] [Full Text] [Related]
29. Biological response modifiers. Interferons, interleukins, and transfer factor.
Kirkpatrick CH
Ann Allergy; 1989 Mar; 62(3):170-6. PubMed ID: 2466425
[TBL] [Abstract][Full Text] [Related]
30. [Personal experiences of immunotherapy using the transfer factor].
D'Amelio R; Franchi F; Aiuti F
Minerva Med; 1976 May; 67(24):1613-6. PubMed ID: 934516
[TBL] [Abstract][Full Text] [Related]
31. Immune system abnormalities in children with facial birth defects.
Miller GC; Say B
Surg Forum; 1979; 30():466-8. PubMed ID: 317182
[No Abstract] [Full Text] [Related]
32. Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis.
Delgado O; Romano EL; Belfort E; Pifano F; Scorza JV; Rojas Z
Clin Immunol Immunopathol; 1981 Jun; 19(3):351-9. PubMed ID: 7249417
[No Abstract] [Full Text] [Related]
33. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
[TBL] [Abstract][Full Text] [Related]
34. [Transfer factor. Fact or fantasy?].
Thestrup-Pedersen K; Zachariae H
Ugeskr Laeger; 1977 Aug; 139(31):1827-33. PubMed ID: 906097
[No Abstract] [Full Text] [Related]
35. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor).
Kyong CU; Wilson GB; Fudenberg HH; Goust JM; Richardson P; Echerd J
Am J Med; 1980 Jun; 68(6):955-61. PubMed ID: 6992573
[TBL] [Abstract][Full Text] [Related]
36. Transfer factor: therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity.
Ammann AJ; Wara D; Salmon S
Cell Immunol; 1974 Apr; 12(1):94-101. PubMed ID: 4156497
[No Abstract] [Full Text] [Related]
37. [The erythrocyte-rosette forming cell (E-RFC) count and results of treatment with transfer factor in herpes simplex keratitis (author's transl)].
Xie LX
Zhonghua Yan Ke Za Zhi; 1981 Jul; 17(4):204-7. PubMed ID: 6802605
[No Abstract] [Full Text] [Related]
38. E-rosette forming count determination and transfer factor treatment in herpetic simplex keratitis.
Xie LX; Kang FY; Du YX
Chin Med J (Engl); 1983 Nov; 96(11):860-4. PubMed ID: 6428821
[No Abstract] [Full Text] [Related]
39. Transfer factor--clinical enigma. Clinical uses of transfer factor (second of two parts).
Graziano FM; Dwyer JM
Conn Med; 1978 Jan; 42(1):1-4. PubMed ID: 620531
[No Abstract] [Full Text] [Related]
40. [Immune substitution].
Barandun S
Verh Dtsch Ges Inn Med; 1978; (84):481-90. PubMed ID: 84449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
